TY - JOUR
T1 - Multiplexed imaging in cancer diagnosis
T2 - Applications and future advances
AU - Kobayashi, Hisataka
AU - Longmire, Michelle R.
AU - Ogawa, Mikako
AU - Choyke, Peter L.
AU - Kawamoto, Satomi
PY - 2010/6
Y1 - 2010/6
N2 - The development of imaging technologies that have sufficient specificity and sensitivity to enable early, accurate detection of cancer and response to therapy has long been a goal in oncology. Various radiological techniques have been used for diagnosis and surveillance of disease recurrence and imaging has revolutionised oncology. However, despite the widespread use of technologies, the ability of currently available imaging methods to facilitate early detection, precise characterisation, and accurate localisation of maligant disease could be improved. The simultaneous use of two or more techniques, contrast reagents, signalling methods, or the coupling of agent and tissue properties to achieve so-called multiplexed imaging is a promising approach. In this review, we provide a broad overview of current and emerging multiplexed, imaging technologies.
AB - The development of imaging technologies that have sufficient specificity and sensitivity to enable early, accurate detection of cancer and response to therapy has long been a goal in oncology. Various radiological techniques have been used for diagnosis and surveillance of disease recurrence and imaging has revolutionised oncology. However, despite the widespread use of technologies, the ability of currently available imaging methods to facilitate early detection, precise characterisation, and accurate localisation of maligant disease could be improved. The simultaneous use of two or more techniques, contrast reagents, signalling methods, or the coupling of agent and tissue properties to achieve so-called multiplexed imaging is a promising approach. In this review, we provide a broad overview of current and emerging multiplexed, imaging technologies.
UR - http://www.scopus.com/inward/record.url?scp=77953541131&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77953541131&partnerID=8YFLogxK
U2 - 10.1016/S1470-2045(10)70009-7
DO - 10.1016/S1470-2045(10)70009-7
M3 - Review article
C2 - 20338808
AN - SCOPUS:77953541131
VL - 11
SP - 589
EP - 595
JO - The Lancet Oncology
JF - The Lancet Oncology
SN - 1470-2045
IS - 6
ER -